John Moroney, MD

John Moroney, MD, and Katherine Kurnit, MD, MPH, discuss which future advances being examined in clinical trials in gynecologic oncology are catching their eyes.

John Moroney, MD, and Katherine Kurnit, MD, MPH, discuss the most interesting recent trends in clinical trials in gynecologic oncology.

John Moroney, MD, and Katherine Kurnit, MD, MPH, discuss their approaches to supporting patients with gynecologic malignancies during clinical trials.

John Moroney, MD, and Katherine Kurnit, MD, MPH, emphasize the importance of timing in gynecologic cancer clinical trials.

John Moroney, MD, and Katherine Kurnit, MD, MPH, discuss how they go about determining which patients are suitable candidates for clinical trials.

John Moroney, MD, and Katherine Kurnit, MD, MPH, discuss the importance of clinical trials in gynecologic oncology.

John Moroney, MD, discusses the evaluation of COM701 plus BMS-986207 and nivolumab in platinum-resistant ovarian cancer.